SmithKline buys research centre

Saturday 08 April 1995 00:02 BST

Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

SmithKline buys research centre

SmithKline Beecham, the pharmaceuticals giant, has paid $120m (about £75m) for the former Sterling Winthrop pharmaceutical research and development complex near Philadelphia. Sterling Winthrop had planned the site as its central research and development operation until it was acquired by the French Sanofi group. SmithKline will move 500 research staff to the plant to fulfil its US development needs.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Stay up to date with notifications from The Independent

Thank you for registering

SmithKline buys research centre

Bookmark popover

Join our commenting forum

Thank you for registering